Medline Inc. (MDLN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 10B 20B 30B FY23: 23.2B FY24: 25.5B FY25: 28.4B FY23 FY24 FY25

Gross Profit Annual

0 3B 6B 9B FY23: 5.9B FY24: 7B FY25: 7.5B FY23 FY24 FY25

Operating Income Annual

0 800M 1.6B 2.4B FY23: 1.2B FY24: 2.1B FY25: 2.2B FY23 FY24 FY25

Net Income Annual

0 400M 800M 1.2B FY23: 234M FY24: 1.2B FY25: 1.2B FY23 FY24 FY25

Cost of Revenue Annual

0 8B 16B 24B FY23: 17.3B FY24: 18.5B FY25: 20.9B FY23 FY24 FY25

Operating Cash Flow Annual

0 700M 1.4B 2.1B FY23: 1.7B FY24: 1.8B FY25: 1.7B FY23 FY24 FY25

Free Cash Flow Annual

0 500M 1B 1.5B FY23: 1.4B FY24: 1.4B FY25: 1.3B FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 300M 600M 900M FY25: 810M FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.